Astrazeneca Pharma India Ltd Share Price
(ASTRAZEN)
₹9042▲0.79%
as on 04:01PM, 23 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 6.62 % |
3 Month Return | + 30.5 % |
1 Year Return | + 71.09 % |
Market Stats | |
Previous Close | ₹8,971.50 |
Open | ₹8,999.00 |
Volume | 21.47K |
Upper Circuit | ₹10,765.50 |
Lower Circuit | ₹7,177.50 |
Market Cap | ₹22,605.00Cr |
P/E Ratio
0PEG Ratio
0Market Cap
₹22,605.00 Cr
P/B Ratio
18.68
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
24.84
AstraZeneca Surrenders Marketing Approval for Olaparib - 15 Apr, 2025
AstraZeneca Receives Approval for TAGRISSO in India - 05 Apr, 2025
AstraZeneca to Discontinue Imdur Production - 28 Mar, 2025
AstraZeneca Faces Tax Challenge Amid Strong Stock Momentum - 19 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, ASTRAZEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 1 Year
In the last 1 year, ASTRAZEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
Foreign Institutions have increased holdings from 2.90% to 2.93% in Dec 2024 quarter
Price Rise
In the last 3 months, ASTRAZEN stock has moved up by 26.8%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 75.00% of holdings in Dec 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 17.00% to 16.85% in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 5.05% to 5.04% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 75% | 0.00 | |
Foreign Institutions | 2.93% | 1.02 | |
Mutual Funds | 5.04% | ||
Retail Investors | 16.85% | ||
Others | 0.18% | 270.61 |
Astrazeneca Pharma India Ltd’s net profit jumped 95.25% since last year same period to ₹30.85Cr in the Q3 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -19.72% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Astrazeneca Pharma India Ltd has declared dividend of ₹24 - translating a dividend yield of 0.44%.
Read More about DividendsBearish
Neutral
Bullish
Astrazeneca Pharma India Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹22,605.00 Cr | 45.38% | 0.51 | NA | NA | |
BUY | ₹30,675.08 Cr | 143.52% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹14,716.93 Cr | 32.28% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹4,989.84 Cr | 1.99% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹14,717.88 Cr | 44.38% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Astrazeneca Pharma India Ltd |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Astrazeneca Pharma India Ltd share price today stands at ₹9042, Open: ₹8999, Previous Close: ₹8971.5, High: ₹9140, Low: ₹8925, 52 Week High: ₹9167.5, 52 Week Low: ₹4800.15.
Today's traded volume of Astrazeneca Pharma India Ltd(ASTRAZEN) is 21.47K.
Today's market capitalisation of Astrazeneca Pharma India Ltd(ASTRAZEN) is ₹22605Cr.
Astrazeneca Pharma India Ltd (ASTRAZEN) share price is ₹9042. It is down -1.37% from its 52 Week High price of ₹9167.5
Astrazeneca Pharma India Ltd (ASTRAZEN) share price is ₹9042. It is up 88.37% from its 52 Week Low price of ₹4800.15